M. Takei

发表

M. Takei, 2012, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Efficacy and safety of the noradrenaline reuptake inhibitor, TAS‐303, in women with stress urinary incontinence: Results of a double‐blind, randomized, placebo‐controlled, early phase II trial

Satoru Takahashi, M. Takei, Kumiko Kato, 2020, International journal of urology : official journal of the Japanese Urological Association.

Z-100, an immunomodulatory extract of Mycobacterium tuberculosis strain Aoyama B, prevents spontaneous lymphatic metastasis of B16-BL6 melanoma.

M. Takei, Takayuki Horii, M. Okamoto, 2014, Biological & pharmaceutical bulletin.

Mechanism for distribution of acotiamide, a novel gastroprokinetic agent for the treatment of functional dyspepsia, in rat stomach.

M. Takei, Ryoko Toda, K. Yoshii, 2011, Journal of pharmaceutical sciences.

ATP-Dependent Transport of a Novel Thromboxane A2 Receptor Antagonist, [2-(4-Chlorophenylsulfonylaminomethyl)-Indan-5-yl]Acetate (Z-335) and Its Xenobiotic Taurine Conjugate (Z-335-Tau) by Rat Bile Canalicular Membrane Vesicles

M. Takei, R. Nishigaki, Y. Kawabata, 2004, Pharmaceutical Research.

Z-360, a novel therapeutic agent for pancreatic cancer, prevents up-regulation of ephrin B1 gene expression and phosphorylation of NR2B via suppression of interleukin-1 β production in a cancer-induced pain model in mice

T. Meyer, M. Takei, K. Yoshinaga, 2010, Molecular pain.

Z-360, a novel cholecystokinin-2/gastrin receptor antagonist, inhibits gemcitabine-induced expression of the vascular endothelial growth factor gene in human pancreatic cancer cells.

M. Takei, K. Yoshinaga, N. Kobayashi, 2010, Biological & pharmaceutical bulletin.

Concentration dependence of 5-aminosalicylic acid pharmacological actions in intestinal mucosa after oral administration of a pH-dependent formulation.

M. Takei, Ryoko Toda, K. Yoshii, 2011, Molecular pharmaceutics.

Effects of Dexamethasone on Tissue Injury and Reconstruction in Ethanol/Steroid Injection Therapy for Allergic Rhinitis

M. Takei, K. Kimata, M. Wu, 2012 .

[Effect of efonidipine hydrochloride (NZ-105) on modification of low density lipoprotein induced by rat cultured endothelial cells].

T. Tanaka, M. Takei, K. Matsuda, 1995, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Effect of polaprezinc on taste disorders in zinc‐deficient rats

M. Takei, K. Yoshinaga, Runa Eta, 2006, BioFactors.

Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, augments anti-tumor activities of X-ray irradiation against B16 melanoma in association with the improvement of type 1T cell responses.

M. Takei, H. Sasaki, K. Yoshinaga, 2004, Biological & pharmaceutical bulletin.

Antiplatelet effect of Z-335, a new orally active and long-lasting thromboxane receptor antagonist.

M. Takei, T. Tanaka, S. Ito, 1998, European journal of pharmacology.

Inhibitory effects of calcium antagonists on mitochondrial swelling induced by lipid peroxidation or amchidonic acid in the rat brain in vitro

M. Takei, A. Mori, M. Hiramatsu, 1994, Neurochemical Research.

A survey on clinical practice of interstitial cystitis in Japan

Y. Homma, M. Takei, Takaaki Ito, 2015, Translational Andrology and Urology.

Japanese guideline for diagnosis and treatment of interstitial cystitis

Y. Homma, M. Takei, Takaaki Ito, 2009, International journal of urology : official journal of the Japanese Urological Association.

Z-350, a new chimera compound possessing α1-adrenoceptor antagonistic and steroid 5α-reductase inhibitory actions

M. Takei, Kenji Yoshida, H. Tamaki, 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

Hormonal Effects of Z-350, Possessing Steroid 5α-Reductase Inhibitory and α1-Adrenoceptor Antagonistic Actions, in the Rat

M. Takei, Kenji Yoshida, T. Kurimoto, 2001 .

Z-100, extracted from Mycobacterium tuberculosis strain Aoyama B, promotes TNF-α production via nucleotide-binding oligomerization domain containing 2 (Nod2)-dependent NF-κB activation in RAW264.7 cells.

M. Takei, Takayuki Horii, Takao Tanaka, 2015, Molecular immunology.

[Implementation of a common clinical path for transurethral resection of prostate (TURP) in multiple hospitals].

M. Takei, M. Imamura, T. Hasegawa, 2004, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Changes in prostate volume in Japanese patients with benign prostatic hyperplasia: Association with other urological measures and risk of surgical intervention

M. Takei, N. Masumori, T. Ichikawa, 2009, International journal of urology : official journal of the Japanese Urological Association.

Z-350, A Novel Compound with α1-Adrenoceptor Antagonistic and Steroid 5α-Reductase Inhibitory Actions: Pharmacological Properties In Vivo

M. Takei, Kenji Yoshida, H. Tamaki, 1999 .

Acotiamide Hydrochloride (Z-338), a New Selective Acetylcholinesterase Inhibitor, Enhances Gastric Motility without Prolonging QT Interval in Dogs: Comparison with Cisapride, Itopride, and Mosapride

J. Tack, M. Takei, Kenji Yoshida, 2011, Journal of Pharmacology and Experimental Therapeutics.

A new thromboxane receptor antagonist, Z-335, ameliorates experimental thrombosis without prolonging the rat tail bleeding time.

M. Takei, T. Tanaka, S. Ito, 1998, Thrombosis research.

Pharmacological evaluation of analgesic effects of the cholecystokinin2 receptor antagonist Z-360 in mouse models of formalin- and cancer-induced pain.

M. Takei, K. Yoshii, Y. Kawabata, 2010, Biological & pharmaceutical bulletin.

Antimetastatic effect of an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, Z-100, through the production of interleukin-12.

M. Takei, H. Sasaki, K. Yoshinaga, 2003, Biological & pharmaceutical bulletin.

Inhibition of human immunodeficiency virus type 1 replication by Z-100, an immunomodulator extracted from human-type tubercle bacilli, in macrophages.

T. Masuda, M. Kannagi, M. Takei, 2004, The Journal of general virology.

Gastric relaxation induced by electrical and chemical stimulation of the area postrema in the rat.

N. Akaike, M. Takei, Yushi Ito, 2008, General physiology and biophysics.

[Effect of efonidipine hydrochloride, a calcium channel blocker, on the experimental cerebral ischemia/anoxia].

T. Mori, M. Takei, S. Ito, 1995, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro

S. Watson, M. Takei, Takao Tanaka, 2008, Cancer Chemotherapy and Pharmacology.

The anticonvulsant effect of citalopram on El mice, and the levels of tryptophan and tyrosine and their metabolites in the brain

M. Takei, I. Yokoi, A. Mori, 1994, Neurochemical Research.

Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in rats.

M. Takei, Ryoko Toda, K. Yoshii, 2011, European journal of pharmacology.

Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs

M. Takei, H. Oka, T. Tanaka, 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Changes in tissue contents of zinc, copper and iron in rats and beagle dogs treated with polaprezinc.

M. Takei, I. Yamaguchi, K. Matsuda, 1996, The Journal of toxicological sciences.

CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells.

T. Meyer, M. Takei, K. Yoshinaga, 2011, Life sciences.

Long‐term safety, tolerability and efficacy of extended‐release tolterodine in the treatment of overactive bladder in Japanese patients

Y. Homma, M. Takei, 2005, International journal of urology : official journal of the Japanese Urological Association.

Z‐505 hydrochloride ameliorates chemotherapy‐induced anorexia in rodents via activation of the ghrelin receptor, GHSR1a

M. Takei, Takao Tanaka, Y. Ohira, 2018, European journal of pharmacology.

Clinical Guideline for Female Lower Urinary Tract Symptoms

Satoru Takahashi, Y. Yoshimura, M. Takei, 2016, Lower urinary tract symptoms.

Clinical guidelines for nocturia

Y. Homma, R. Sakakibara, H. Kakizaki, 2010, International journal of urology : official journal of the Japanese Urological Association.

Clinical Guidelines for Female Lower Urinary Tract Symptoms (second edition)

Satoru Takahashi, Y. Yoshimura, M. Takei, 2021, International journal of urology : official journal of the Japanese Urological Association.

Defining overactive bladder as hypersensitivity

Y. Homma, H. Kakizaki, M. Takei, 2007, Neurourology and urodynamics.

Haploinsufficiency of 8p22 may influence cancer-specific survival in prostate cancer.

K. Naito, K. Sasaki, M. Takei, 2007, Cancer genetics and cytogenetics.

Tension‐free vaginal tape surgery for stress urinary incontinencne: A prospective multicentered study in Japan

A. Kondo, M. Takei, Kumiko Kato, 2006, International journal of urology : official journal of the Japanese Urological Association.

Quality of life assessments in women operated on by tension-free vaginal tape (TVT)

A. Kondo, M. Takei, H. Toma, 2005, International Urogynecology Journal.

Voiding and incontinence frequencies: Variability of diary data and required diary length

Y. Homma, M. Takei, M. Gotoh, 2002, Neurourology and urodynamics.

Voiding dynamics in women with stress urinary incontinence and high‐stage cystocele

S. Naito, M. Takei, N. Seki, 2011, International journal of urology : official journal of the Japanese Urological Association.

Burden of male stress urinary incontinence: A survey among urologists in Japan

T. Matsuda, M. Igawa, Satoru Takahashi, 2009, International journal of urology : official journal of the Japanese Urological Association.

Polaprezinc, a zinc compound, is distributed to the lingual epithelium and increases its zinc concentration in zinc-deficient rats.

M. Takei, Y. Kawabata, Takayuki Horii, 2009, Life sciences.

Predictives regarding outcome after transurethral resection for prostatic adenoma associated with detrusor underactivity.

S. Naito, M. Takei, N. Seki, 2006, Urology.

Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction

S. Naito, M. Takei, N. Seki, 2009, Neurourology and urodynamics.

Analysis of prognostic factors regarding the outcome after a transurethral resection for symptomatic benign prostatic enlargement

S. Naito, M. Takei, N. Seki, 2006, Neurourology and urodynamics.

Predictability of Conventional Tests for the Assessment of Bladder Outlet Obstruction in Benign Prostatic Hyperplasia

Y. Homma, Takuhiro Yamaguchi, M. Takei, 1998, International journal of urology : official journal of the Japanese Urological Association.

The development of the ICIQ‐UAB: A patient reported outcome measure for underactive bladder

B. Blok, G. V. van Koeveringe, M. Takei, 2019, Neurourology and urodynamics.

Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice.

M. Takei, Takao Tanaka, Y. Ohira, 2017, European journal of pharmacology.

Characterization of peroxisomes in Tetrahymena pyriformis

M. Takei, T. Suga, Takafumi Watanabe, 1982 .

The Asia‐Pacific AMS800 artificial urinary sphincter consensus statement

M. Takei, Y. Kaiho, H. Masuda, 2022, International journal of urology : official journal of the Japanese Urological Association.

Current use of the artificial urinary sphincter and its long‐term durability: A nationwide survey in Japan

T. Matsuda, M. Igawa, Satoru Takahashi, 2009, International journal of urology : official journal of the Japanese Urological Association.

Surgical and Patient Reported Outcomes of Artificial Urinary Sphincter Implantation: A Multicenter, Prospective, Observational Study

T. Mitsui, M. Takei, M. Yokoyama, 2017, The Journal of urology.

Low quality of life in men with chronic prostatitis-like symptoms

S. Fukuhara, M. Takei, Y. Kakehi, 2022, Prostate Cancer and Prostatic Diseases.

Chronic administration of citalopram inhibited El mouse convulsions and decreased monoamine oxidase-A activity.

M. Takei, I. Yokoi, A. Mori, 1994, Acta medica Okayama.

Symptoms and noninvasive test parameters that clinically differentiate detrusor underactivity from bladder outlet obstruction without a pressure‐flow‐based diagnosis in men with lower urinary tract symptoms

M. Takei, O. Yamaguchi, R. Takahashi, 2020, Neurourology and urodynamics.

A Prediction Model for Detrusor Underactivity Based on Symptoms and Noninvasive Test Parameters in Men with Lower Urinary Tract Symptoms: An Analysis from a Large Group of Patients Undergoing Pressure Flow Studies.

A. Yokomizo, M. Takei, O. Yamaguchi, 2020, The Journal of urology.

Efficacy and safety of intravesical instillation of KRP‐116D (50% dimethyl sulfoxide solution) for interstitial cystitis/bladder pain syndrome in Japanese patients: A multicenter, randomized, double‐blind, placebo‐controlled, clinical study

Y. Homma, T. Mitsui, M. Takei, 2021, International journal of urology.

Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: Analysis of 282 Japanese patients

M. Takei, Takaaki Ito, T. Ueda, 2007 .

Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate

S. Naito, M. Takei, N. Seki, 2008, Neurourology and urodynamics.

Dual-acting agents with α1-adrenoceptor antagonistic and steroid 5α-reductase inhibitory activities. Synthesis and evaluation of arylpiperazine derivatives

M. Takei, O. Kitagawa, Kiyoshi Yoshida, 1999 .

[Continuous bladder irrigation following transurethral resection of the prostate (TURP)].

M. Takei, A. Terai, S. Saito, 2007, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Twelve Months Follow‐up of Injection of OnabotulinumtoxinA into Vesical Submucosa for Refractory Non‐neurogenic Overactive Bladder

Y. Homma, M. Takei, M. Gotoh, 2013, Lower urinary tract symptoms.

Summary of the Urodynamics Workshops on IC Kyoto, Japan

M. Takei, Y. Sugino, P. Irwin, 2003, International journal of urology : official journal of the Japanese Urological Association.

The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity

S. Naito, M. Takei, R. Takahashi, 2008, Neurourology and urodynamics.

Contact Dermatitis Due To Alstroemeria

M. Takei, Y. Takase, Takashi Ito, 1986 .

Actual behaviour of N-butyl-2-cyanoacrylate (histoacryl) in a blood vessel: a model of the varix.

M. Takei, T. Suga, N. Nakamura, 2002, Endoscopy.

Surgical treatment of female stress urinary incontinence with a transobturator tape (Monarc): Short‐term results of a prospective multicenter study

Y. Yoshimura, M. Takei, Kumiko Kato, 2010, The journal of obstetrics and gynaecology research.

Predictive factors for the effect of the α1‐D/A adrenoceptor antagonist naftopidil on subjective and objective criteria in patients with neurogenic lower urinary tract dysfunction

Y. Homma, H. Kakizaki, M. Takei, 2011, BJU international.

Effects of the new anti-ulcer drug nizatidine on prostaglandins in the rat gastric mucosa.

M. Takei, T. Omata, Y. Segawa, 1991, Arzneimittel-Forschung.

Acotiamide Hydrochloride (Z-338), a New Selective Acetylcholinesterase Inhibitor, Enhances Gastric Motility without Prolonging QT Interval in Dogs: Comparison with Cisapride, Itopride, and Mosapride

J. Tack, M. Takei, Kenji Yoshida, 2011, Journal of Pharmacology and Experimental Therapeutics.

Z-505, an Oral Ghrelin Receptor Agonist, Attenuates Anorexia After Total Gastrectomy in Rats.

M. Takei, T. Uno, Takao Tanaka, 2019, The Journal of surgical research.

Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice.

M. Takei, Takao Tanaka, Y. Ohira, 2017, European journal of pharmacology.

Outcomes of artificial urinary sphincter implantation in patients with diabetes mellitus: A subgroup analysis

T. Mitsui, M. Takei, M. Yokoyama, 2022, International journal of urology : official journal of the Japanese Urological Association.

PREDICTIVE FACTORS FOR THE EFFECT OF ALPHA1- ADRENOCEPTOR ANTAGONIST ON SUBJECTIVE AND OBJECTIVE PARAMETERS IN PATIENTS WITH NEUROGENIC LOWER URINARY TRACT DYSFUNCTION: SPECIAL FOCUS ON ALPHA1-D/A ADRENOCEPTOR ANTAGONIST NAFTOPIDIL

Y. Homma, H. Kakizaki, M. Takei, 2007 .